In vitro modelling of bacterial pneumonia: a comparative analysis of widely applied complex cell culture models

Laure Mahieu1, Laurence Van Moll1, Linda De Vooght1

  • 1Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.

FEMS Microbiology Reviews
|February 27, 2024
PubMed

Insights

Advanced in vitro models like lung-on-a-chip offer improved bacterial pneumonia research. These complex cell culture models enhance understanding of host-pathogen interactions and drug efficacy for lower respiratory tract infections.

Area of Science:

  • Microbiology and Immunology
  • Biomedical Engineering
  • Cell Biology

Background:

  • Bacterial pneumonia significantly impacts global health, necessitating robust laboratory models for research.
  • Current research models struggle to fully replicate complex human lung environments for studying bacterial pneumonia.
  • Advanced in vitro models are crucial for bridging the gap between traditional cell cultures and animal studies.

Approach:

  • This review examines cutting-edge in vitro models for bacterial pneumonia, including air-liquid interface, spheroid, organoid, and lung-on-a-chip systems.
  • A comprehensive literature search focused on six key bacterial pathogens: Pseudomonas aeruginosa, Mycoplasma pneumoniae, Haemophilus influenzae, Mycobacterium tuberculosis, Streptococcus pneumoniae, and Staphylococcus aureus.
  • Analysis includes common cell lines, methodological trends, and assay readouts in bacterial pneumonia modeling.

Key Points:

  • Complex in vitro models provide controlled, high-throughput platforms for studying bacterial pneumonia.
  • Lung-on-a-chip and organoid models show promise in mimicking human lung physiology for infection studies.
  • Standardization and validation of these advanced models are critical for reliable results.

Conclusions:

  • Advanced in vitro models are essential for accurate bacterial pneumonia research, offering detailed insights into host-pathogen dynamics.
  • Further development and validation of complex cellular models will accelerate the discovery of new treatments for lower respiratory tract infections.
  • Emphasis on data transparency and model validation is key to advancing the field of bacterial pneumonia in vitro modeling.

Related Concept Videos